| Overall and comparative risk of herpes zoster with pharmacotherapy for inflammatory bowel diseases: a nationwide cohort study N Khan, D Patel, C Trivedi, Y Shah, G Lichtenstein, J Lewis, YX Yang Clinical Gastroenterology and Hepatology 16 (12), 1919-1927. e3, 2018 | 120 | 2018 |
| Albumin as a prognostic marker for ulcerative colitis N Khan, D Patel, Y Shah, C Trivedi, YX Yang World Journal of Gastroenterology 23 (45), 8008, 2017 | 77 | 2017 |
| Management of anemia in patients with inflammatory bowel disease (IBD) D Patel, C Trivedi, N Khan Current treatment options in gastroenterology 16, 112-128, 2018 | 57 | 2018 |
| Risk factors for SARS-CoV-2 infection and course of COVID-19 disease in patients with IBD in the Veterans Affair Healthcare System N Khan, N Mahmud, C Trivedi, W Reinisch, JD Lewis Gut 70 (9), 1657-1664, 2021 | 48 | 2021 |
| Impact of anti-tumor necrosis factor and thiopurine medications on the development of COVID-19 in patients with inflammatory bowel disease: a nationwide Veterans administration … N Khan, D Patel, D Xie, J Lewis, C Trivedi, YX Yang Gastroenterology 159 (4), 1545-1546. e1, 2020 | 43 | 2020 |
| Safety of herpes zoster vaccination among inflammatory bowel disease patients being treated with anti‐TNF medications N Khan, Y Shah, C Trivedi, JD Lewis Alimentary Pharmacology & Therapeutics 46 (7), 668-672, 2017 | 30 | 2017 |
| Efficacy of live attenuated herpes zoster vaccine in patients with inflammatory bowel diseases N Khan, C Trivedi, H Kavani, E Medvedeva, J Lewis, YX Yang Clinical Gastroenterology and Hepatology 17 (7), 1341-1347, 2019 | 26 | 2019 |
| Incidence of acute myeloid leukemia and myelodysplastic syndrome in patients with inflammatory bowel disease and the impact of thiopurines on their risk N Khan, D Patel, C Trivedi, H Kavani, T Pernes, E Medvedeva, J Lewis, ... Official journal of the American College of Gastroenterology| ACG 116 (4 …, 2021 | 23 | 2021 |
| Incidence, duration, and management of anemia: a nationwide comparison between IBD and non-IBD populations D Patel, YX Yang, C Trivedi, H Kavani, D Xie, E Medvedeva, J Lewis, ... Inflammatory Bowel Diseases 26 (6), 934-940, 2020 | 21 | 2020 |
| Frequency of herpes zoster vaccination among inflammatory bowel disease patients N Khan, C Trivedi, H Kavani, J Lewis, YX Yang Inflammatory Bowel Diseases 25 (2), 345-351, 2019 | 21 | 2019 |
| Efficacy of recombinant zoster vaccine in patients with inflammatory bowel disease N Khan, L Wang, C Trivedi, T Pernes, M Patel, D Xie, YX Yang Clinical Gastroenterology and Hepatology 20 (7), 1570-1578. e1, 2022 | 19 | 2022 |
| Efficacy of vedolizumab in a nationwide cohort of elderly inflammatory bowel disease patients N Khan, T Pernes, A Weiss, C Trivedi, M Patel, E Medvedeva, D Xie, ... Inflammatory Bowel Diseases 28 (5), 734-744, 2022 | 17 | 2022 |
| The impact of IBD medications on risk of pneumonia and pneumonia‐related hospitalisation: a nationwide cohort study of 56 410 IBD patients N Khan, D Patel, C Trivedi, T Pernes, H Kavani, D Xie, YX Yang Alimentary Pharmacology & Therapeutics 55 (1), 64-72, 2022 | 14 | 2022 |
| Incidence of infections and malignancy among elderly male patients with IBD exposed to vedolizumab, prednisone, and 5-ASA medications: a nationwide retrospective cohort study N Khan, T Pernes, A Weiss, C Trivedi, M Patel, D Xie, YX Yang Advances in Therapy 38, 2586-2598, 2021 | 14 | 2021 |
| Repeated occurrences of basal cell cancer in patients with inflammatory bowel disease treated with immunosuppressive medications N Khan, D Patel, C Trivedi, H Kavani, E Medvedeva, T Pernes, D Xie, ... Official journal of the American College of Gastroenterology| ACG 115 (8 …, 2020 | 13 | 2020 |
| The natural history of newly diagnosed ulcerative colitis in patients with concomitant primary sclerosing cholangitis N Khan, C Trivedi, Y Shah, E Cole, J Lewis, YX Yang Inflammatory bowel diseases 24 (9), 2062-2067, 2018 | 13 | 2018 |
| The severity of herpes zoster in inflammatory bowel disease patients treated with anti-TNF agents N Khan, C Trivedi, Y Shah, D Patel, J Lewis, YX Yang Inflammatory bowel diseases 24 (6), 1274-1279, 2018 | 12 | 2018 |
| The efficacy and safety of switching from originator infliximab to single or double switch biosimilar among a nationwide cohort of inflammatory bowel disease patients N Khan, D Patel, T Pernes, M Patel, C Trivedi, E Medvedeva, D Xie, ... Crohn's & Colitis 360 3 (2), otab022, 2021 | 10 | 2021 |
| Mortality associated with development of squamous cell cancer in patients with inflammatory bowel diseases receiving treatment with thiopurines N Khan, H Lee, C Trivedi, H Kavani, E Medvedeva, D Xie, JD Lewis, ... Clinical Gastroenterology and Hepatology 17 (11), 2262-2268, 2019 | 10 | 2019 |
| Safety of recombinant zoster vaccine in patients with inflammatory bowel disease N Khan, C Trivedi, F Aberra, T Pernes, YX Yang Journal of Crohn's and Colitis 16 (9), 1505-1507, 2022 | 7 | 2022 |
Dhruvan PatelUniversity of Pennsylvania在 pennmedicine.upenn.edu 的电子邮件经过验证
